PURPOSE: Tumor microenvironments show remarkable tumor pO(2) heterogeneity, as seen in prior EPR pO(2) images (EPROI). pO(2) correlation with hypoxia response proteins is frustrated by large rapid pO(2) changes with position. PROCEDURES: To overcome this limitation, biopsies stereotactically located in the EPROI were used to explore the relationship between vascular endothelial growth factor A (VEGF) concentrations in living mouse tumors and the local EPROI pO(2). RESULTS: Quantitative ELISA VEGF concentrations correlated (p = 0.0068 to 0.019) with mean pO(2), median pO(2), and the fraction of voxels in the biopsy volume with pO(2) less than 3, 6, and 10 Torr. CONCLUSIONS: This validates EPROI hypoxic fractions at the molecular level and provides a new paradigm for the assessment of the relationship, in vivo, between hypoxia and hypoxia response proteins. When translated to human subjects, this will enhance understanding of human tumor pathophysiology and cancer response to therapy.
PURPOSE:Tumor microenvironments show remarkable tumorpO(2) heterogeneity, as seen in prior EPR pO(2) images (EPROI). pO(2) correlation with hypoxia response proteins is frustrated by large rapid pO(2) changes with position. PROCEDURES: To overcome this limitation, biopsies stereotactically located in the EPROI were used to explore the relationship between vascular endothelial growth factor A (VEGF) concentrations in living mousetumors and the local EPROI pO(2). RESULTS: Quantitative ELISA VEGF concentrations correlated (p = 0.0068 to 0.019) with mean pO(2), median pO(2), and the fraction of voxels in the biopsy volume with pO(2) less than 3, 6, and 10 Torr. CONCLUSIONS: This validates EPROI hypoxic fractions at the molecular level and provides a new paradigm for the assessment of the relationship, in vivo, between hypoxia and hypoxia response proteins. When translated to human subjects, this will enhance understanding of humantumor pathophysiology and cancer response to therapy.
Authors: Atsuko Matsumoto; Shingo Matsumoto; Anastasia L Sowers; Janusz W Koscielniak; Nancy J Trigg; Periannan Kuppusamy; James B Mitchell; Sankaran Subramanian; Murali C Krishna; Ken-Ichiro Matsumoto Journal: Magn Reson Med Date: 2005-12 Impact factor: 4.668
Authors: Martyna Elas; Kang-Hyun Ahn; Adrian Parasca; Eugene D Barth; David Lee; Chad Haney; Howard J Halpern Journal: Clin Cancer Res Date: 2006-07-15 Impact factor: 12.531
Authors: D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst Journal: Cancer Res Date: 1996-03-01 Impact factor: 12.701
Authors: Boris Epel; Subramanian V Sundramoorthy; Martyna Krzykawska-Serda; Matthew C Maggio; Mark Tseytlin; Gareth R Eaton; Sandra S Eaton; Gerald M Rosen; Joseph P Y Kao; Howard J Halpern Journal: J Magn Reson Date: 2016-12-31 Impact factor: 2.229
Authors: Andrey A Kuzhelev; Victor M Tormyshev; Olga Yu Rogozhnikova; Dmitry V Trukhin; Tatiana I Troitskaya; Rodion K Strizhakov; Olesya A Krumkacheva; Matvey V Fedin; Elena G Bagryanskaya Journal: Z Phys Chem (N F) Date: 2016-10-05 Impact factor: 2.408
Authors: Boris Epel; Matthew C Maggio; Eugene D Barth; Richard C Miller; Charles A Pelizzari; Martyna Krzykawska-Serda; Subramanian V Sundramoorthy; Bulent Aydogan; Ralph R Weichselbaum; Victor M Tormyshev; Howard J Halpern Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-08 Impact factor: 7.038
Authors: Dmitry V Trukhin; Olga Yu Rogozhnikova; Tatiana I Troitskaya; Vladimir G Vasiliev; Michael K Bowman; Victor M Tormyshev Journal: Synlett Date: 2015-12-23 Impact factor: 2.454